Myopia is a real public health challenge in Asia, and China currently has one of the fastest rates of myopia progression in the world. The event was organized by Wenzhou Medical University with which Essilor created a shared research laboratory (WEIRC) focusing on myopia in children in June 2013.
The conference is held every two years and offers a unique occasion to have the world’s top myopia experts discussing latest findings from the prevalence of myopia in different geographic regions to solutions to reduce its progression. Hot topics included the influence of light (and outdoor activities) on the development and prevention of myopia as well as concern over the rising incidence of pathological myopia that leads to blindness.
Essilor had a significant scientific presence at the event: 8 R&D experts attended, 14 posters exploring different aspects of the Group’s work on myopia were on show and two speakers from Wenzhou Medical University – Essilor International Research – Center (WEIRC) gave conference presentations.
Myopia is a strategic axis for Essilor’s R&D teams worldwide. Latest estimates show that by 2030, 2.7 billion people will have myopia and that the percentage of those with a high degree of myopia (more than -5D) will rise even faster, leading to increased risk of severe eye diseases. The Group continues to focus attention on finding the best solutions to reduce the impact of myopia on quality of life through providing the most adapted equipment and treatment for individuals.